-
Fury claims Joshua bout is off, calls for Usyk trilogy
-
Dukascopy Bank Unveils AI-Powered Trading, 25,000+ Stock CFDs and a New Flagship E-Banking App
-
British family bids to row back against suicide taboo
-
Tech firms rally but Asian markets mixed, with eyes on US inflation
-
China's teenage 223cm basketball player 'just a little girl'
-
Nepal holds day of mourning as families pray missing still alive
-
Tokyo's Shinjuku to ban more than half of vacation rentals
-
African players in Europe: Mbeumo fires solo goal as United draw
-
Australian Rules limits contact training to reduce concussion
-
Malaysia cancels haze emergency, but warns problems remain
-
Germany's Merz under pressure from far-right election triumph
-
Philippine sensation Eala looks forward to Asian Games 'fun'
-
Nepal tunnel rescues face 'unprecedented' challenge
-
Jakarta airport extends closure after volcano eruption
-
Mourinho's Real Madrid European revival bid starts with Inter reunion
-
Lonely woman director in Venice sees industry backsliding on gender
-
Solomons PM survives attempt to oust government
-
Tech firms rally on mixed day for Asian markets, with eyes on US inflation
-
Ohtani 'unlikely' to pitch again this season, says Dodgers manager
-
World number one An sends Asian Games warning with China hat-trick
-
Driver thanks 'superhero' rival for saving him from flaming race car
-
PSG go for three in a row as Champions League returns
-
Can dogs sniff cancer? AI joins the hunt in India
-
"Super-human' Alcaraz books US Open quarter-final clash with Shelton
-
Shelton steams into US Open quarter-final clash with Alcaraz
-
ECB set to hike interest rates as Iran war flares anew
-
25 years on, America seeks to keep 9/11 memories alive
-
AI data centers are less thirsty now, tech giants say
-
'Trumpapalooza' tests Republican bet on unpopular US president
-
North Korea vows nuclear-armed navy as US ally drills open
-
Pegula tops Cirstea to reach US Open quarter-finals
-
Under-fire Labuschagne named in Australia Test squad for South Africa
-
Australians could opt out of social media algorithms under new law
-
Best Way to Protect A 401(k) in 2026: Guide Released by Experts
-
Genflow Biosciences PLC Announces Appointment of Investor Relations Adviser
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 07
-
Enjoying the moment: Alcaraz steps it up to reach US Open quarter-finals
-
Tiafoe tops Medvedev in straight sets at US Open
-
Five dead, five injured after Amazon cargo plane overshoots Miami runway
-
Zverev seeks US Open last eight as Osaka faces Rybakina
-
La Rochelle half-backs lead fightback against Toulouse
-
Alcaraz turns up heat to reach US Open quarters
-
US envoys have 'more effective proposals': Ukraine official
-
Gatti salvages Juve draw with AC Milan in Serie A
-
Defending champion Alcaraz powers into US Open quarter-finals
-
Sinayoko stars as unbeaten Paris FC down Marseille
-
Amazon cargo plane overshoots Miami runway, hits vehicles, catches fire
-
Still on top: 'Spider-Man' dominates North American box office
-
Toll from Yemen clashes passes 300 as civilians flee homes
-
Zelensky in fresh talks with US envoys: Ukraine official
NDT Pharmaceuticals Completes Acquisition of Good Salt(TM) Life, LLC
ATHENS, GA / ACCESS Newswire / September 9, 2025 / NDT Pharmaceuticals Inc. (OTC:NDTP) ("NDTP" or the "Company") today announced that it has completed the acquisition of Good Salt Life, LLC, an Athens, Georgia-based innovator in biosafety and infection control. The transaction closed on Friday, September 5, 2025.
Good Salt Life, a wholly owned subsidiary of NDTP, is a vertically integrated biosafety company that designs, manufactures, and deploys infection control ecosystems combining proprietary hardware, EPA-approved chemistries, and data-driven disinfection protocols. Its solutions serve both animal and human environments across 11 countries and 8 industries, with customers ranging from food producers and hospitals to cruise lines and major sports organizations.
Good Salt Life's brand ecosystem spans consumer pet care, home care, cosmetics, antimicrobial chemistry, and cutting edge chemical delivery technology, including products trusted by leading institutions such as Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott, and the NFL.
"This acquisition marks a transformative moment for NDTP," said Zach O'Shea, President and CEO of NDT Pharmaceuticals. "Good Salt Life's mission of combining sustainability, innovation, and wellness aligns perfectly with our vision for growth. Together, we are building a company that is not only committed to shareholder value but also to creating cleaner, safer, and healthier solutions for everyday life."
Additional details on the transaction and integration plans will be shared in the coming weeks.
About NDT Pharmaceuticals, Inc. (OTC:NDTP)
NDT Pharmaceuticals, Inc. (OTC:NDTP) is a publicly traded company focused on advancing innovative consumer health and wellness solutions. With its recent acquisition of Good Salt Life Inc., NDTP has expanded its strategic direction into sustainable, science-driven products that promote healthier living. The Company is committed to building value through investments in brands that protect people, pets, and the planet while aligning with growing consumer demand for eco-friendly and health-conscious alternatives.
About Good Salt Life, LLC
Good Salt Life, LLC is dedicated to promoting vitality through eco-friendly, nature-derived products that support healthier living environments. With a focus on innovation and sustainability, the company offers safe and effective solutions for home, pet, personal care, and animal health. Through strategic partnerships, including collaborations in the B2B animal health sector, Good Salt Life, LLC continues to drive advancements that benefit both people and animals. For more information, visit www.goodsaltlife.com.
Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's current expectations and speak only as of the date of this release. Actual results may differ materially from the Company's current expectations. Except as required by law, the Company does not undertake any responsibility to revise or update any forward-looking statements.
Contact:
[email protected]
SOURCE: NDT Pharmaceuticals Inc.
View the original press release on ACCESS Newswire
D.Moore--AMWN